Načítá se...
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8(+) and CD4(+) T cells
The success of immune system‐based cancer therapies depends on a broad immune response engaging a range of effector cells and mechanisms. Immune mobilizing monoclonal T cell receptors (TCRs) against cancer (ImmTAC™ molecules: fusion proteins consisting of a soluble, affinity enhanced TCR and an anti...
Uloženo v:
| Vydáno v: | Immunology |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629433/ https://ncbi.nlm.nih.gov/pubmed/28640942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.12779 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|